This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Guangwei Yang - Innovator in Anti-PD-1 Antibodies
Introduction
Guangwei Yang is a notable inventor based in Cheshire, CT (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions that address critical health challenges.
Latest Patents
Guangwei Yang holds a patent for Anti-PD-1 antibodies. This invention relates to new anti-PD-1 (Programmed cell death 1) antibodies and antigen-binding fragments thereof. These antibodies are designed for therapeutic and diagnostic methods and compositions, showcasing their potential in cancer treatment and immunotherapy.
Career Highlights
Yang is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role involves research and development in the field of immunology, where he applies his expertise to advance medical science. His innovative approach has led to the creation of valuable therapeutic options.
Collaborations
Throughout his career, Guangwei Yang has collaborated with esteemed colleagues, including Pankaj Gupta and Nicole K Garaffa. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the field.
Conclusion
Guangwei Yang's contributions to the development of Anti-PD-1 antibodies highlight his role as a key innovator in biotechnology. His work not only advances scientific knowledge but also has the potential to improve patient outcomes in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile